GlaxoSmithKline | 借入資本



Loan Capital 変化する 日付
AbbVie USD 60.34B 1.83B 2024-12
Alcon AG USD 4.54B 395M 2024-12
Almirall EUR 351.76M 538K 2024-06
Amgen USD 56.55B 305M 2024-12
AstraZeneca USD 27.73B 2.29B 2024-12
Bayer EUR 34.55B 2.12B 2024-12
Biogen USD 4.55B 1.4M 2024-12
Bristol-Myers Squibb USD 47.6B 1.07B 2024-12
Eli Lilly USD 28.53B 518.3M 2024-12
Fresenius EUR 13.28B 1.81B 2024-12
Fresenius Medical Care EUR 9.76B 202.37M 2024-12
Galapagos EUR 8.24M 1000K 2024-12
Genmab DKK 937M 41M 2024-12
Gilead Sciences USD 24.9B 3.46B 2024-12
GlaxoSmithKline GBP 14.64B 1.39B 2024-12
Glaxosmithkline GBP 14.64B 1.39B 2024-12
GRIFOLS EUR 8.68B 155.99M 2024-12
Hikma Pharmaceutical USD 1.06B 31M 2024-06
Lonza CHF 4.24B 602M 2024-12
Merck EUR 7.88B 62M 2024-09
Merck USD 34.46B 520M 2024-12
Novartis USD 22.93B 2.41B 2024-12
Novo Nordisk 51.45B 156M 2024-09
Orion EUR 297.2M 69.7M 2024-12
Pfizer USD 57.4B 597M 2024-12
Philips EUR 7.11B 3M 2024-12
Recordati EUR 1.26B 87.43M 2024-09
Regeneron Pharmaceuticals USD 2.7B 720.4M 2024-12
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 12.5B 1.84B 2024-06
Smith & Nephew USD 3.26B 17M 2024-12
UCB EUR 2.82B 166M 2024-12



GlaxoSmithKline 借入資本 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Mar 2025.